Key Highlights
- AssureCare acquires Clinigence Health, enhancing its analytics platform Akumen.
- This acquisition expands market leadership in healthcare analytics.
- Integration improves clinical decision-making, patient outcomes, and operational efficiency.
- Payors, providers, and pharmacies benefit from the expanded capabilities.
- Leadership affirms the transformative potential of this acquisition.
Source: PR Newswire
Notable Quotes
- “Bringing Clinigence Health into the AssureCare family exponentially strengthens our actionable analytics platform, Akumen.” — Dr. Yousuf Ahmad, President & CEO at AssureCare
- “This partnership amplifies Clinigence Health’s ability to innovate and also enhances our commitment to delivering transformative healthcare solutions.” — Chuck Kandzierski, President at Clinigence Health
SoHC's Take
The acquisition of Clinigence Health marks a strategic move by AssureCare to further cement its leadership in healthcare analytics and value-based care. By integrating Clinigence’s provider-focused analytics into Akumen, AssureCare now offers a more comprehensive solution that spans across the entire healthcare spectrum—payors, providers, and pharmacies. This expansion will likely drive better clinical decisions and improve operational efficiencies, positioning AssureCare to provide unmatched value to its clients. As the industry continues to shift toward value-based care, AssureCare is well-equipped to address the increasing demands for data-driven healthcare solutions.
Heading
Key Highlights CalmWave closes a $5.25M financing round led by Third Prime with contributions from Catalyst by Wellstar, Silver Circle, and ...
Key Highlights Alice Koehler appointed Managing Director of OMRON Healthcare North America. Koehler brings 25+ years of global experience in ...
Key Highlights Koda Health introduces Kidney Action Planning to support Chronic Kidney Disease (CKD) management with cutting-edge tools. Features include gamified patient ...
Key Highlights Northwell Health’s Aging Revolution Summit will take place virtually and in-person in NYC on December 3, 2024. Key themes: Therapeutics, ...
Key Highlights $5M Series A funding led by Empactful Capital to fuel growth and innovation. Investment will support product development, strategic accounts, and new market ...
Key Highlights New Lantern raises $19M Series A funding, led by Benchmark, totaling $23M raised to date. Platform automates 25% of ...
